Medicinal Psychedelics for Neuroinflammatory conditions - Depression, Severe Headaches, OCD, Addiction and Autism
62 clinical trials with Psilocybin are registered Today’s post is about treating a wide range of conditions that share neuroinflammation in common, by targeting the serotonin receptor 5-HT 2A . Severely disabling cluster headaches, that were seen as untreatable, have been resolved by monthly micro dosing with psilocybin. Psilocybin is a naturally occurring prodrug compound produced by more than 200 species of fungus, including magic mushrooms. Psilocybin is quickly converted by the body into Psilocin. Psilocin Binding Profile Target Affinity Species K i (nM) SERT 3,801.0 Human 5-HT 1A 567.4 Human 5-HT 1B 219.6 Human 5-HT 1D 36.4 Human 5-HT 1E 52.2 Human 5-HT 2A 107.2 Human 5...